// App-Quantinova.ai

: Chronic pain treatment satisfaction in musculoskeletal disease: differences between osteoarthritis and chronic low back pain in medication switching, opioid use, and utilization of non-pharmacologic treatments

Researchers

Presenter

  • J. Mali

Principal Investigators

  • J. Nascimento

  • J. Atkinson

  • R. Robinson

  • J. Bobula

  • M. Port

  • V. Bruemmer

Medical Centers

  • Emerge Ortho, Durham, NC, USA,

  • Vanguard Strategy, London, United Kingdom,

  • Pfizer Inc., Walton Oaks, United Kingdom

  • Eli Lilly and Company, Indianapolis, IN

  • Pfizer Inc, New York, NY

Locations

  • United States

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Chronic low back pain

  • Osteoarthritis

  • Chronic pain

Biomarkers

  • N/A

Drug/Treatment

  • Epimorph

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved